Buspirone to improve compliance in venlafaxine-induced movement disorder

Pavlovic, Zoran M

doi:10.1017/s1461145704004638

Cited by 11 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It could be possible that continuing treatment with venlafaxine might be contributing to this, but he had a drugless period of almost 3 weeks. Also, we could not find any report about venlafaxine‐induced dystonia; however, a case of bruxism induced by venlafaxine has been reported 8 …”

mentioning

confidence: 75%

Persistent dystonia induced by fluoxetine

Bilen

Saka

et al. 2008

Internal Medicine Journal

View full text Add to dashboard Cite

Serotonin-selective re-uptake inhibitors are prescribed widely because they are regarded as having less severe side-effects compared with tricyclics and monoamine oxidase inhibitors. With this popularity, increasing attention has been drawn to their adverse effects. Development of extrapyramidal symptoms has been reported in some patients while taking fluoxetine, a commonly used serotonin-selective re-uptake inhibitor. Here, we report a case of persistent dystonia, thought to be associated with short-term fluoxetine use, which required treatment with botulinum toxin type A.

show abstract

mentioning

confidence: 75%

Persistent dystonia induced by fluoxetine

Bilen

Saka

et al. 2008

Internal Medicine Journal

View full text Add to dashboard Cite

show abstract

“…However, none of those medications have been reported to induce DB. Given that there are increasing reports of DB associated with antidepressant drugs (paroxetine[13], sertraline[14], fluvoxamine[15], venlafaxine[16], fluoxetine[17], and atomoxetine[18]), our clinical impression was that the patient's DB was secondary to venlafaxine use. The cause-and-effect relationship is supported by the following observations: (1) The patient exhibited no previous history of bruxism or other movement disorder before taking venlafaxine; (2) Duloxetine 60 mg/d was irregularly taken for 2 mo without occurrence of DB; and (3) DB occurred 4 mo after switching from duloxetine 60 mg/d to venlafaxine 150 mg/d.…”

Section: Discussionmentioning

confidence: 99%

“…Bostwick et al[14] claimed that buspirone was effective in treating sertraline-induced DB. Pavlovic et al[16] found that buspirone was effective in venlafaxine-induced DB. It is also reported that tandospirone can result in remission of paroxetine-induced DB[12].…”

Section: Discussionmentioning

confidence: 99%

Long-term follow-up of a patient with venlafaxine-induced diurnal bruxism treated with an occlusal splint: A case report

Chen¹,

Yan²

2019

WJCC

View full text Add to dashboard Cite

BACKGROUND Bruxism is a jaw-muscle activity characterized by the clenching or grinding of teeth. It can be divided into nocturnal bruxism and diurnal bruxism (DB). DB secondary to antidepressants is rare and refractory. Reports associated with antidepressant-induced DB are mostly anecdotal without long-term follow-up. The effect of drug intervention on antidepressant-induced DB is still contested. We herein report the first case of successful treatment of venlafaxine-induced DB with an occlusal splint. CASE SUMMARY This case report describes detailed 7-year follow-up of a patient with venlafaxine-induced DB treated with an occlusal splint. The patient who complained about involuntary daytime tooth grinding after taking venlafaxine for a period of 4 mo and was diagnosed with venlafaxine-induced DB. Subsequently, an occlusal splint with modified bilateral buccal-pterygoid pads was used to treat his tooth grinding and to protect the dental structures from tooth wearing. The patient reported remission of symptoms after several months of treatment. His grinding activity was gradually and stably controlled after 2 years, with an almost complete recovery from DB after 6 years. CONCLUSION The maxillary buccal-pterygoid splint can be used as a noninvasive approach to treat venlafaxine-induced DB.

show abstract

“…Buspironun özellikle ilaçların yan etkisi olarak ortaya çıkmış ikincil bruksizm üzerinde iyileştirici etkisi olduğu rapor edilmiştir. 48,52,55,58,64,71,[92][93][94][95] Pavlovic 95 buspironun venlafaksin kaynaklı uyanıklık bruksizminde etkili olduğunu bulmuşdur. Fitzgerald ve ark.…”

Section: Ht1aunclassified

Psi̇kotrop İlaçlarin Bruksi̇zm Eti̇yoloji̇si̇ Ve Tedavi̇si̇ndeki̇ Etki̇si̇: Güncel Bi̇lgi̇ler Işiğinda Bruksi̇zme Genel Bakiş

Miloğlu¹,

Yılmaz²,

Güller³

et al. 2021

Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi

View full text Add to dashboard Cite

Bruxism, also known as teeth grinding, is an unusual activity that affects people's quality of life to a certain extent. Bruxism that occurs during the day and / or during sleep is thought to have a multifactorial etiology. There are many studies on the etiology of bruxism, but certain issues have not been fully clarified in these studies. Various methods are used in the treatment, but the main factor must be found in order to apply effective treatment of bruxism. As well as psychotropic drugs used in the treatment of bruxism, there are also psychotropic drugs that initiate bruxism or induce bruxism. The effects of these drugs at different doses and durations vary. In this review, we investigated the etiology of bruxism and the effects of psychotropic drugs on initiation, induction and treatment of bruxism. Thus, we tried to emphasize the effect of drugs used in evaluating or treating bruxism.

show abstract

Buspirone to improve compliance in venlafaxine-induced movement disorder

Cited by 11 publications

References 6 publications

Persistent dystonia induced by fluoxetine

Persistent dystonia induced by fluoxetine

Long-term follow-up of a patient with venlafaxine-induced diurnal bruxism treated with an occlusal splint: A case report

Psi̇kotrop İlaçlarin Bruksi̇zm Eti̇yoloji̇si̇ Ve Tedavi̇si̇ndeki̇ Etki̇si̇: Güncel Bi̇lgi̇ler Işiğinda Bruksi̇zme Genel Bakiş

Contact Info

Product

Resources

About